Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer. It is an ALK1 inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.